Name
OÜ Eesti Farmaatsia Grupp
Registry code
11028295
VAT number
EE100933802
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
22.04.2004 (20)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
77399 - Renting and operational leasing of other machinery, equipment and tangible assets not classified elsewhere 46191 - Agents involved in the sale of a variety of goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Evelyn Saluste 16.02.1974 (50) | 100% - 2 556.00 EUR | - | Direct ownership | Founder |
| Veiko Saluste 26.01.1968 (56) | - | Board member | Other control or influence (contractual, family or other relationships) |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pharmapark OÜ 16308757 | 40% - 4 000.00 EUR | - | - | Founder |
| PharmaPark Production OÜ 16729463 | 40% - 1 000.00 EUR | - | - | Founder |
| 2019 28.02.2021 | 2020 02.07.2021 | |
|---|---|---|
| Total Revenue | 145 104 € | 159 744 € |
| Net profit (loss) for the period | 127 479 € | 158 017 € |
| Profit Margin | 88% | 99% |
| Current Assets | 2 103 550 € | 2 059 766 € |
| Fixed Assets | 274 388 € | 274 388 € |
| Total Assets | 2 377 938 € | 2 334 154 € |
| Current Liabilities | 302 463 € | 100 662 € |
| Non Current Liabilities | - | - |
| Total Liabilities | - | - |
| Share Capital | - | - |
| Equity | 2 075 475 € | 2 233 492 € |
| Employees | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | 296 400 € | 31 680.79 € | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | 324 020.65 € | 59 827.46 € | - | - |
| 2021 Q4 | 453 299.55 € | 29 655.19 € | - | - |
| 2021 Q3 | -516 299.94 € | - | - | 1 |
| 2021 Q2 | 904 382.06 € | 110 359.76 € | - | 1 |
| 2021 Q1 | 36 246.06 € | 11 010.66 € | - | 1 |
| 2020 Q4 | 51 006.06 € | 12 849.57 € | - | 1 |
| 2020 Q3 | 36 246.06 € | 4 799.66 € | - | 1 |
| 2020 Q2 | 36 246.06 € | - | - | 1 |
| 2020 Q1 | 36 246.06 € | 7 162.23 € | - | 1 |
